Research programme: herpes simplex virus therapeutic - Piramal Phytocare

Drug Profile

Research programme: herpes simplex virus therapeutic - Piramal Phytocare

Alternative Names: Arnophyte; PP-1010525

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Piramal Life Sciences
  • Developer Piramal Phytocare
  • Class
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Herpes simplex virus infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Herpes-simplex-virus-infections in India (Topical)
  • 10 Sep 2012 Pharmacodynamics data from a preclincial study in Herpes simplex virus infections presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2012)
  • 15 Jun 2012 Preclinical trials in Herpes simplex virus infections in India (topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top